The European Journal of Health Economics

, Volume 11, Issue 2, pp 205–213 | Cite as

A social preference valuations set for EQ-5D health states in Flanders, Belgium

Original Paper


This study aimed at deriving a preference valuation set for EQ-5D health states from the general Flemish public in Belgium. A EuroQol valuation instrument with 16 health states to be valued on a visual analogue scale was sent to a random sample of 2,754 adults. The initial response rate was 35%. Eventually, 548 (20%) respondents provided useable valuations for modeling. Valuations for 245 health states were modeled using a random effects model. The selection of the model was based on two criteria: health state valuations must be consistent, and the difference with the directly observed valuations must be small. A model including a value decrement if any health dimension of the EQ-5D is on the worst level was selected to construct the social health state valuation set. A comparison with health state valuations from other countries showed similarities, especially with those from New Zealand. The use of a single preference valuation set across different health economic evaluations within a country is highly preferable to increase their usability for policy makers. This study contributes to the standardization of outcome measurement in economic evaluations in Belgium.


Quality of life Value set EuroQol EQ-5D Cost–utility analysis 

JEL Classification




This research was part of my Ph.D. thesis some years ago. I wish to thank my supervisor Prof. Dr. Katrien Kesteloot for supporting me during the work.


  1. 1.
    Dolan, P.: Modeling valuations for EuroQol health states. Med Care 35, 1095–1108 (1997)CrossRefGoogle Scholar
  2. 2.
    MVH Group: The measurement and valuation of health. Final report on the modelling of valuation tariffs. York Centre for Health Economics (1995)Google Scholar
  3. 3.
    Greiner, W., Claes, C., van Busschbach, J., Graf von der Schulenburg, J.: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6, 124–130 (2005)CrossRefGoogle Scholar
  4. 4.
    Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., Hamashima, C., Hisashige, A., Tamura, M.: Estimating an EQ-5D population value set: the case of Japan. Health Econ 11, 341–353 (2002)CrossRefGoogle Scholar
  5. 5.
    Wittrup-Jensen, K.U., Lauridsen, J.T., Gudex, C., Brooks, R., Pedersen, K.M.: Estimating Danish EQ-5D tariffs using TTO and VAS. In: Norinder, A., Pedersen, K., Roos, P. (eds.) 18th Plenary Meeting of the EuroQol Group, pp. 257–92. IHE, The Swedish Institute for Health Economics (2002)Google Scholar
  6. 6.
    Lamers, L.M., McDonnell, J., Stalmeier, P., Krabbe, P., Busschbach, J.: The Dutch Tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 15, 1121–1132 (2006)CrossRefGoogle Scholar
  7. 7.
    Shaw, J.W., Johnson, J.A., Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43, 203–220 (2005)CrossRefGoogle Scholar
  8. 8.
    Jelsma, J., Hansen, K., De Weerdt, W., De Cock, P., Kind, P.: How do Zimbabweans value health states? Popul Health Metrics 1, 11 (2003)CrossRefGoogle Scholar
  9. 9.
    Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21, 7–16 (2001)CrossRefGoogle Scholar
  10. 10.
    Claes, C., Greiner, W., Uber, A., Graf von der Schulenburg, J.: An interview-based comparison of the TTO and VAS values given to EuroQol states of health by the general German population. In: Greiner, W., Graf von der Schulenburg, J., Piercy, J. (eds.) EQ Plenary Meeting. Hannover (1999)Google Scholar
  11. 11.
    Ohinmaa, A., Eija, H., Sintonen, H.: Modelling EuroQol values of Finnish adult population. In: Badia, X., Herdman, M., Segura, A., (eds.) EuroQol Plenary Meeting. Barcelona. Institut Universitari de Salut Publica de Catalunya (1995)Google Scholar
  12. 12.
    Ohinmaa, A., Sintonen, H.: Inconsistencies and modelling of the Finnish EuroQol (EQ-5D) preference values. Paper presented tot the 15th EuroQol Plenary Meeting, Hanover (1998)Google Scholar
  13. 13.
    Devlin, N.J., Hansen, P., Kind, P., Williams, A.: Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Econ 12, 529–544 (2003)CrossRefGoogle Scholar
  14. 14.
    Prevolnik Rupel, V., Rebolj, M.: The Slovenian VAS Tariff based on valuations of EQ-5D health states from the general population. In: Cabasés, J.M., Gaminde, I. (eds.) 17th Plenary Meeting of the EuroQol Group, pp. 23–47. Universidad Pública de Navarra (2001)Google Scholar
  15. 15.
    Badia, X., Roset, M., Monserrat, S., Herdman, M.: The Spanish VAS tariff based on valuations of EQ-5D health states from the general population. Proceedings of the EuroQol Plenary Meeting, Rotterdam (1997)Google Scholar
  16. 16.
    Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., Buxton, M., Dolan, P., Kind, P., Krabbe, P., Ohinmaa, A., Parkin, D., Roset, M., Sintonen, H., Tsuchiya, A., de Charro, F.: A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4, 222–231 (2003)CrossRefGoogle Scholar
  17. 17.
    Szende, A., Oppe, M., Devlin, N.: EQ-5D value sets: inventory. Comparative Review and User Guide. Springer, Dordrecht (2007)CrossRefGoogle Scholar
  18. 18.
    Gudex, C., Dolan, P., Kind, P., Williams, A.: Health state valuations from the general public using the visual analogue scale. Qual Life Res 5, 521–531 (1996)CrossRefGoogle Scholar
  19. 19.
    Nord, E.: EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 18, 25–36 (1991)CrossRefGoogle Scholar
  20. 20.
    Brooks, R., Jendteg, S., Lindgren, B., Persson, U., Björk, S.: EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 18, 37–48 (1991)CrossRefGoogle Scholar
  21. 21.
    van Agt, H.M., Essink-Bot, M.L., Krabbe, P.F., Bonsel, G.J.: Test–retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1982) 39, 1537–1544 (1994)Google Scholar
  22. 22.
    Badia, X., Fernandez, E., Segura, A.: Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Pub Health 5, 87–93 (1995)CrossRefGoogle Scholar
  23. 23.
    Kind, P., Dolan, P., Gudex, C., Williams, A.: Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 316, 736–741 (1998)Google Scholar
  24. 24.
    Dolan, P., Kind, P.: Inconsistency and health state valuations. Soc Sci Med 42, 609–615 (1996)CrossRefGoogle Scholar
  25. 25.
    O’Brien, B.J., Drummond, M.F.: Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5–389 (1994)Google Scholar
  26. 26.
    Gudex, C., Dolan, P.: Valuing health states: the effect of duration. Discussion Paper (1995)Google Scholar
  27. 27.
    Dolan, P.: The effect of experience of illness on health state valuations. J Clin Epidemiol 49, 551–564 (1996)CrossRefGoogle Scholar
  28. 28.
    Badia, X., Monserrat, S., Roset, M., Herdman, M.: Feasibility, validity and test–retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res 8, 303–310 (1999)CrossRefGoogle Scholar
  29. 29.
    Cleemput, I., Van Wilder, P., Vrijens, F., Huybrechts, M., Ramaekers, D.: Guidelines for Pharmacoeconomic Evaluations in Belgium. KCE Reports. Belgian Health Care Knowledge Centre (KCE), Bruxelles (2008)Google Scholar
  30. 30.
    Cleemput, I., van Wilder, P., Huybrechts, M., Vrijens, F.: Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests. Value Health 2008; Early View (2008)Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Belgian Health Care Knowledge Centre, Administratief Centrum KruidtuinBrusselsBelgium

Personalised recommendations